{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T15:37:56Z","timestamp":1773589076270,"version":"3.50.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Aceruloplasminemia is a rare autosomal recessive inherited disorder. Mutations in the ceruloplasmin gene cause depressed ferroxidase activity leading to iron accumulation. The clinical phenotype is highly variable: anemia, retinopathy, diabetes mellitus, psychiatric disorders, and neurological symptoms including parkinsonian disorders and dementia are the main features of this disease. Characterized by high serum ferritin with low transferrin saturation, aceruloplasminemia uniquely combines brain, liver and systemic iron overload. We report here four new cases of aceruloplasminemia in a consanguineous North-African family. Genetic sequencing revealed a homozygous missense variant c.656T&amp;gt;A in exon 4 of the ceruloplasmin gene, which had been described previously as of \u201cunknown significance\u201d in the dbSNP database and never associated with ACP in the HGMD database. Ferroxidase activity was strongly depressed. Clinical manifestations varied among cases. The proband exhibited mild microcytic anemia, diabetes mellitus, psychosis and parkinsonism, whereas the other cases were asymptomatic or mildly anemic, although high serum ferritin and brain iron deposition were documented in all of them. Therapeutic management was complex. The proband started deferoxamine treatment when already symptomatic and he rapidly declined. In the asymptomatic cases, the treatment was associated with poor tolerance and was discontinued due to anemia requiring red blood cell transfusion. Our series illustrates the need for new therapeutic approaches to aceruloplasminemia.<\/jats:p>","DOI":"10.3389\/fnins.2022.906360","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T05:58:14Z","timestamp":1651471094000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["A New Pathogenic Missense Variant in a Consanguineous North-African Family Responsible for a Highly Variable Aceruloplasminemia Phenotype: A Case-Report"],"prefix":"10.3389","volume":"16","author":[{"given":"Herv\u00e9","family":"Lobbes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quitterie","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Mainbourg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Savy-Stortz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Ropert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Bardou-Jacquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Durupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1002\/mdc3.13062","article-title":"Akbostanci MC. Aceruloplasminemia presenting with asymmetric chorea due to a novel frameshift mutation","volume":"7","author":"Aydemir","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/bjh.13401","article-title":"Combination-therapy with concurrent deferoxamine and deferiprone is effective in treating resistant cardiac iron-loading in aceruloplasminaemia","volume":"171","author":"Badat","year":"2015","journal-title":"Br. J. Haematol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s10897-008-9169-9","article-title":"Standardized human pedigree nomenclature: update and assessment of the recommendations of the National Society of Genetic Counselors","volume":"17","author":"Bennett","year":"2008","journal-title":"J. Genet. Couns."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1212\/WNL.0000000000001956","article-title":"Iron chelation therapy to prevent the manifestations of aceruloplasminemia","volume":"85","author":"Bove","year":"2015","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0955-3886(00)00087-4","article-title":"The importance of non-transferrin bound iron in disorders of iron metabolism","volume":"23","author":"Breuer","year":"2000","journal-title":"Transfus. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/clinchem\/44.11.2313","article-title":"Automated measurement of serum ferroxidase activity","volume":"44","author":"Erel","year":"1998","journal-title":"Clin. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jhep.2010.04.039","article-title":"Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation","volume":"53","author":"Finkenstedt","year":"2010","journal-title":"J. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0140-6736(04)15436-6","article-title":"Non-invasive assessment of hepatic iron stores by MRI","volume":"363","author":"Gandon","year":"2004","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003594","article-title":"Aceruloplasminemia with psychomotor excitement and neurological sign was improved by minocycline (case report)","volume":"95","author":"Hayashida","year":"2016","journal-title":"Medicine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev.nutr.22.012502.114457","article-title":"Ceruloplasmin metabolism and function","volume":"22","author":"Hellman","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"B11","unstructured":"2022"},{"key":"B12","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.bbadis.2010.07.011","article-title":"Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin","volume":"1802","author":"Kono","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"B13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.braindev.2007.01.001","article-title":"Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate","volume":"29","author":"Kuhn","year":"2007","journal-title":"Brain Dev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1055\/s-0034-1383650","article-title":"Aceruloplasminaemia: a family with a novel mutation and long-term therapy with deferasirox","volume":"47","author":"Lindner","year":"2015","journal-title":"Horm. Metab. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.revmed.2020.06.002","article-title":"L'ac\u00e9rul\u00e9oplasmin\u00e9mie h\u00e9r\u00e9ditaire, une pathologie \u00e0 ne pas m\u00e9conna\u00eetre","volume":"41","author":"Lobbes","year":"2020","journal-title":"Revue M\u00e9d. Interne"},{"key":"B16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0168-8278(02)00042-9","article-title":"Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights","volume":"36","author":"Lor\u00e9al","year":"2002","journal-title":"J. Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fnins.2019.00325","article-title":"Aceruloplasminemia: a severe neurodegenerative disorder deserving an early diagnosis","volume":"13","author":"Marchi","year":"2019","journal-title":"Front. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000148691","article-title":"The neurological presentation of ceruloplasmin gene mutations","volume":"60","author":"McNeill","year":"2008","journal-title":"ENE"},{"key":"B19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/neup.12149","article-title":"Aceruloplasminemia","volume":"35","author":"Miyajima","year":"2015","journal-title":"Neuropathology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1212\/WNL.53.3.617","article-title":"Estimation of the gene frequency of aceruloplasminemia in Japan","volume":"53","author":"Miyajima","year":"1999","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.410370515","article-title":"Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family","volume":"37","author":"Morita","year":"1995","journal-title":"Ann. Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12876-020-01237-8","article-title":"New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson's disease","volume":"20","author":"Ondrejkovi\u010dov\u00e1","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fnut.2018.00103","article-title":"Inherited disorders of iron overload","volume":"5","author":"Pantopoulos","year":"2018","journal-title":"Front. Nutr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6578","DOI":"10.1523\/JNEUROSCI.22-15-06578.2002","article-title":"Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury","volume":"22","author":"Patel","year":"2002","journal-title":"J. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.parkreldis.2018.02.036","article-title":"Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia","volume":"51","author":"Pelucchi","year":"2018","journal-title":"Parkins. Relat. Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1517\/17530059.2013.763794","article-title":"Molecular diagnosis of hemochromatosis","volume":"7","author":"Piperno","year":"2013","journal-title":"Expert Opin. Med. Diagn."},{"key":"B27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3389\/fnins.2018.00903","article-title":"Aceruloplasminemia: waiting for an efficient therapy","volume":"12","author":"Piperno","year":"2018","journal-title":"Front. Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10072-016-2756-x","article-title":"Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment","volume":"38","author":"Poli","year":"2017","journal-title":"Neurol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s10072-021-05613-4","article-title":"Aceruloplasminemia: a multimodal imaging study in an Italian family with a novel mutation","volume":"43","author":"Salsone","year":"2021","journal-title":"Neurol. Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jamaneurol.2018.3230","article-title":"Neurodegeneration with brain iron accumulation: a novel mutation in the ceruloplasmin gene","volume":"76","author":"Stelten","year":"2019","journal-title":"JAMA Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.2169\/internalmedicine.52.0102","article-title":"Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation","volume":"52","author":"Suzuki","year":"2013","journal-title":"Intern. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/hepr.12292","article-title":"Case of presymptomatic aceruloplasminemia treated with deferasirox","volume":"44","author":"Tai","year":"2014","journal-title":"Hepatol. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.3390\/ijms21072374","article-title":"Genetic and clinical heterogeneity in thirteen new cases with aceruloplasminemia. Atypical anemia as a clue for an early diagnosis","volume":"21","author":"Vila Cuenca","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/dme.12712","article-title":"Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series","volume":"32","author":"Vroegindeweij","year":"2015","journal-title":"Diabetic Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/jimd.12064","article-title":"Aceruloplasminemia: neurodegeneration with brain iron accumulation associated with psychosis","volume":"42","author":"Vroegindeweij","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13023-020-01385-w","article-title":"Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports","volume":"15","author":"Vroegindeweij","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.parkreldis.2016.12.010","article-title":"New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients","volume":"36","author":"Vroegindeweij","year":"2017","journal-title":"Parkins. Relat. Disord."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-1086","article-title":"Novel ceruloplasmin gene mutation causing aceruloplasminemia with diabetes in a Chinese woman: a case report","author":"Xiao","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1007\/s11011-021-00799-0","article-title":"A novel ceruloplasmin mutation identified in a Chinese patient and clinical spectrum of aceruloplasminemia patients","volume":"36","author":"Xu","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.2169\/internalmedicine.9496-17","article-title":"Pancytopenia and myelodysplastic changes in aceruloplasminemia: a case with a novel pathogenic variant in the ceruloplasmin gene","volume":"57","author":"Yamamura","year":"2018","journal-title":"Intern. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.15252\/emmm.201708361","article-title":"Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia","volume":"10","author":"Zanardi","year":"2018","journal-title":"EMBO Mol. Med."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.906360\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T05:58:18Z","timestamp":1651471098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.906360\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":41,"alternative-id":["10.3389\/fnins.2022.906360"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2022.906360","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"article-number":"906360"}}